Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial
2025 · Nature Medicine · 7 citations
https://doi.org/10.1038/s41591-025-03928-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
23
Citations
2
h-index
1
i10-index
Lisa-Marie Lanz is an academic researcher from University of Geneva. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 6 publications.
Click to start Chat